Constellation Brands Inc. (STZ) is scheduled to report third-quarter fiscal 2018 results on Jan 5. Constellation Brands has been on a roll owing to strong brand portfolio, strategic initiatives and robust quarterly results.
Rite Aid Corporation (RAD) is slated to report third-quarter fiscal 2018 results on Jan 3. After the aforementioned sale of stores to Walgreens, Rite Aid is poised to improve financial leverage and balance sheet.
There’s no getting around it — 2017 was a disaster for drugstore chain Rite Aid Corporation (NYSE:RAD). The beleaguered organization, along with owners of RAD stock, were counting on a major acquisition from rival Walgreens Boots Alliance Inc (NASDAQ:WBA). When all was said and done though, Walgreens was only allowed to buy less than half the number of stores it intended to acquire when the deal was first announced in October of 2015.
Walgreens Boots' (WBA) Retail Pharmacy USA division continues to witness comparable prescription growth as well as a robust retail prescription market.
Top Research Daily for Chevron, United Technologies & Charter Communications
This year has been a rocky ride for Rite Aid Corporation (NYSE:RAD), with the RAD stock price down 75% in 2017. At the beginning of the year, there was hope that Walgreens Boots Alliance Inc (NASDAQ:WBA) would pull off the deal to buy Rite Aid. Walgreens quickly worked out another agreement with Rite Aid and regulators gave their stamp of approval in September.
CVS Health (CVS) looks for ways to return to growth.
Fred's (FRED) has been struggling with its dismal comps performance stemming from receding traffic and store closures. Also, management cancelled its quarterly dividend recently.
AmerisourceBergen (ABC) enters a strategic agreement with Walgreen Boots Alliance.
Walgreens and CVS are battling it out for customers. Here’s how the two drug store giants matched up in a price comparison.
While the political debate over a national healthcare system rages on, health insurance companies are pocketing Americans' hard-earned money -- and sometimes using less than ethical methods to do it.
Walgreens (WBA) along with privately-held global investment firm KKR completes the acquisition of Pharmerica for $1.4 billion. The merger agreement was announced in August.
Rite Aid Corporation (NYSE:RAD) has a new lease on life. Now that the sale of stores to Walgreens Boots Alliance Inc (NASDAQ:WBA) has begun, Rite Aid has the cash flow it needs to reduce a crushing debt burden and RAD stock has bounced off its lows as a result. The only thing left to decide is if Rite Aid will have a second act as a regional drug store or if it destined to sell itself off.
The Finish Line, Inc. (FINL) is slated to release third-quarter fiscal 2018 results on Dec 21. The company is not immune to the intense promotions in the athletic space along with the shift of most retailers to digital and differentiated retailing.
We expect NIKE Inc. (NKE) to beat expectations when it reports second-quarter fiscal 2018 results on Dec 21. NIKE's robust growth and innovation efforts have been reflected in its robust earnings surprise trend.
Bed Bath & Beyond Inc. (BBBY) is slated to release third-quarter fiscal 2017 results on Dec 20. The company has been lately grappling with soft traffic trends and weak margins.
Cardinal Health (CAH) consistently works on launching products and carrying out acquisitions to boost revenues.